Cited by 931Tryptophan and brain disordersSchizophrenia research and treatmentNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Open access

Khandaker, Golam M, Cousins, Lesley, Deakin, Julia, Lennox, Belinda R, Yolken, Robert, Jones, Peter B·2015·The Lancet Psychiatry

DOI 10.1016/s2215-0366(14)00122-9PMC PMC4595998

Open this paper in CoChat — free account

Abstract

Complex interactions between the immune system and the brain might have important aetiological and therapeutic implications for neuropsychiatric brain disorders. A possible association between schizophrenia and the immune system was postulated over a century ago, and is supported by epidemiological and genetic studies pointing to links with infection and inflammation. Contrary to the traditional view that the brain is an immunologically privileged site shielded behind the blood-brain barrier, studies in the past 20 years have noted complex interactions between the immune system, systemic inflammation, and the brain, which can lead to changes in mood, cognition, and behaviour. In this Review, we describe some of the important areas of research regarding innate and adaptive immune response in schizophrenia and related psychotic disorders that, we think, will be of interest to psychiatric clinicians and researchers. We discuss potential mechanisms and therapeutic implications of these findings, including studies of anti-inflammatory drugs in schizophrenia, describe areas for development, and offer testable hypotheses for future investigations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(14)00122-9

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848

Show all 135 references

Sorted by citations

Items 201–300 of 931

Adjunctive minocycline for major mental disorders: A systematic review
Zheng, W., Zhu, X., Zhang, Q., Cheng, G., Cai, D.-B., He, J., Ng, C. H., Ungvari, G. S., Peng, X.-J., Ning, Y., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119858286 · Cited by 38
Elevated environmental PM2.5 increases risk of schizophrenia relapse: Mediation of inflammatory cytokines
Gao, J., Wei, Q., Pan, R., Yi, W., Xu, Z., Duan, J., Tang, C., He, Y., Liu, X., Song, S., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.142008 · Cited by 37
Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
Lin, C., Chen, K., Yu, J., Feng, W., Fu, W., Yang, F., Zhang, X., & Chen, D. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03569-5 · Cited by 40
Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis
Islam, M. R., Sohan, M., Daria, S., Masud, A. A., Ahmed, M. U., Roy, A., & Shahriar, M. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231198828 · Cited by 41
Smoking and Serum Lipid Profiles in Schizophrenia
An, H.-M., Tan, Y.-L., Tan, S.-P., Shi, J., Wang, Z.-R., Yang, F.-D., Huang, X., Soars, J. C., Kosten, T. R., & Zhang, X. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0022-0 · Cited by 36
The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia
Kozłowska, E., Agier, J., Wysokiński, A., Łucka, A., Sobierajska, K., & Brzezińska‐Błaszczyk, E. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.138 · Cited by 37
A human iPSC-astroglia neurodevelopmental model reveals divergent transcriptomic patterns in schizophrenia
Szabó, A., Akkouh, I. A., Vandenberghe, M., Osete, J. R., Hughes, T., Heine, V. M., Smeland, O. B., Glover, J. C., Andreassen, O. A., & Djurovic, S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01681-4 · Cited by 39
Olfactory impairment in psychiatric disorders: Does nasal inflammation impact disease psychophysiology?
Hasegawa, Y., Ma, M., Sawa, A., Lane, A. P., & Kamiya, A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02081-y · Cited by 40
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Martini, S., Gemma, A., Ferrari, M., Cosentino, M., & Marino, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043125 · Cited by 39
Inflammation, Dopaminergic Brain and Bilirubin
Jayanti, S. D., Verde, C. D., Tiribelli, C., & Gazzin, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411478 · Cited by 39
Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders
Pollak, T. A., Rogers, J. P., Nagele, R. G., Peakman, M., Stone, J. M., David, A. S., & McGuire, P. K. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby021 · Cited by 37
Contribution of astrocytes to familial risk and clinical manifestation of schizophrenia
Koskuvi, M., Lehtonen, Š., Trontti, K., Keuters, M. H., Wu, Y., Koivisto, H., Ludwig, A., Plotnikova, L. M., Virtanen, P. L. J., Räsänen, N., et al. (2021) · Glia · doi:10.1002/glia.24131 · Cited by 34
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies
Sapienza, J., Spangaro, M., Guillemin, G. J., Comai, S., & Bosia, M. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01519-0 · Cited by 35
Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula
Bernstein, H., Hildebrandt, J., Dobrowolny, H., Steiner, J. H., Bogerts, B., & Pahnke, J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.036 · Cited by 34
B-cells and schizophrenia: A promising link or a finding lost in translation?
van Mierlo, H. C., Broen, J. C. A., Kahn, R. S., & de Witte, L. D. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.043 · Cited by 34
A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.015 · Cited by 35
Relation between self-perceived stress, psychopathological symptoms and the stress hormone prolactin in emerging psychosis
Studerus, E., Ittig, S., Beck, K., Cacho, N. D., Vila‐Badia, R., Butjosa, A., Usall, J., & Riecher‐Rössler, A. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.06.014 · Cited by 34
Aggregative trans-eQTL analysis detects trait-specific target gene sets in whole blood
Dutta, D., He, Y. M., Saha, A., Arvanitis, M., Battle, A. J., & Chatterjee, N. (2022) · Nature Communications · doi:10.1038/s41467-022-31845-9 · Cited by 32
Associations between sleep quality and inflammatory markers in patients with schizophrenia
Fang, S., Suzuki, K., Lim, C. L., Chung, M.-S., Ku, P., & Chen, L. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.09.032 · Cited by 36
Alterations of eicosanoids and related mediators in patients with schizophrenia
Wang, D., Sun, X., Yan, J., Ren, B., Cao, B., Lu, Q., Liu, Y., Zeng, J., Huang, N., Xie, Q., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.002 · Cited by 33
Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study
Kappelmann, N., Khandaker, G. M., Dal, H., Štochl, J., Kosidou, K., Jones, P. B., Dalman, C., & Karlsson, H. (2018) · Psychological Medicine · doi:10.1017/s0033291718000831 · Cited by 33
Self-citation
Traumagenics: At the intersect of childhood trauma, immunity and psychosis
Chase, K. A., Melbourne, J. K., Rosen, C., McCarthy‐Jones, S., Jones, N., Feiner, B. M., & Sharma, R. P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.097 · Cited by 36
Delirium due to hip fracture is associated with activated immune-inflammatory pathways and a reduction in negative immunoregulatory mechanisms
Thisayakorn, P., Thipakorn, Y., Tantavisut, S., Sirivichayakul, S., & Maes, M. H. J. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04021-y · Cited by 33
Microglia sequelae: brain signature of innate immunity in schizophrenia
Rodrigues‐Neves, A. C., Ambrósio, A. F., & Gomes, C. A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02197-1 · Cited by 36
Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients
Bejerot, S., Sigra, S., Henriksson, E. W., Eklund, D., Hylén, U., & Humble, M. B. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.12.003 · Cited by 33
Increased inflammasome activity in markedly ill psychiatric patients: an explorative study
Hylén, U., Eklund, D., Humble, M., Bartoszek, J., Särndahl, E., & Bejerot, S. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577119 · Cited by 32
Transcriptional level of inflammation markers associates with short-term brain structural changes in first-episode schizophrenia
Cui, L., Wang, X.-Y., Fu, Y., Liu, X., Wei, Y., Zhao, S., Gu, Y.-W., Fan, J.-W., Wu, W.-J., Gong, H., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02963-y · Cited by 33
Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan
Wang, W.-C., Lu, M., Chen, V. C., Ng, M., Huang, K.-Y., Hsieh, M., Hsieh, M., McIntyre, R. S., Lee, Y. L., & Lee, C. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173063 · Cited by 34
Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia
Tan, Y., Li, Y., Tan, S., Wang, Z., Yang, F., Cao, B., Zunta‐Soares, G. B., Soares, J. C., & Zhang, X. Y. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.038 · Cited by 31
Immune activation in lactating dams alters sucklings' brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: A novel neurodevelopmental model of sex-specific psychopathology
Arad, M., Piontkewitz, Y., Albelda, N., Shaashua, L., & Weiner, I. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.015 · Cited by 33
Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients
Wei, L., Du, Y., Wu, W., Fu, X., & Xia, Q. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.002 · Cited by 31
Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
Mohite, S., de Campos-Carli, S. M., Rocha, N. P., Sharma, S., de Miranda, A. S., Barbosa, I. G., Salgado, J. V., Silva, A. C. S. E., & Teixeira, A. L. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.023 · Cited by 31
Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 1966
Miller, B. J., Herzig, K., Jokelainen, J. J., Karhu, T., Keinanen-Kiukaanniemi, S. M., Järvelin, M., Veijola, J. M., Viinamäki, H. T., Tanskanen, P., Jääskeläinen, E., et al. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01134-x · Cited by 31
Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia
Saleem, A., Qurat-ul-Ain, Q.-U.-A., & Akhtar, M. F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.895668 · Cited by 34
Elevated brain-derived cell-free DNA among patients with first psychotic episode – a proof-of-concept study
Lubotzky, A., Pelov, I., Teplitz, R., Neiman, D., Smadja, A., Zemmour, H., Piyanzin, S., Ochana, B.-L., Spalding, K. L., Gläser, B., et al. (2022) · eLife · doi:10.7554/elife.76391 · Cited by 30
Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort
Osimo, E. F., Stochl, J., Zammit, S., Lewis, G., Jones, P. B., & Khandaker, G. M. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2019.152143 · Cited by 30
Self-citation
Transcriptome analysis reveals disparate expression of inflammation-related miRNAs and their gene targets in iPSC-astrocytes from people with schizophrenia
Akkouh, I. A., Hughes, T., Steen, V. M., Glover, J. C., Andreassen, O. A., Djurovic, S., & Szabó, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.01.037 · Cited by 32
Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex
Toriumi, K., Berto, S., Koike, S., Usui, N., Dan, T., Suzuki, K., Miyashita, M., Horiuchi, Y., Yoshikawa, A., Asakura, M., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102057 · Cited by 33
Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD
Yang, L. L., Stiernborg, M., Skott, E., Söderström, Å., Giacobini, M., & Lavebratt, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.10.005 · Cited by 29
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives
Vita, A., Nibbio, G., & Barlati, S. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae013 · Cited by 34
Neuroretinal Alterations in Schizophrenia and Bipolar Disorder: An Updated Meta-analysis
Sheehan, N., Bannai, D., Silverstein, S. M., & Lizano, P. L. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae102 · Cited by 28
Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders
Kokkosis, A. G., & Tsirka, S. E. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266163 · Cited by 29
Comparative efficacy of psychological interventions on immune biomarkers: A systematic review and network meta-analysis (NMA)
Ballesio, A., Zagaria, A., Vacca, M., Pariante, C. M., & Lombardo, C. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.05.006 · Cited by 30
Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures
Runtz, L., Girard, B., Toussenot, M., Espallergues, J., de Maudave, A. F., Milman, A., de Bock, F., Ghosh, C., Guérineau, N. C., Pascussi, J., et al. (2017) · Epilepsia · doi:10.1111/epi.13942 · Cited by 29
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Cortez, I. L., da Silva, N. R., Guimarães, F. S., & Gomes, F. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587154 · Cited by 29
The Cellular Dysfunction of the Brain–Blood Barrier from Endothelial Cells to Astrocytes: The Pathway towards Neurotransmitter Impairment in Schizophrenia
Stanca, S., Rossetti, M., Panichi, L. B., & Bongioanni, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021250 · Cited by 28
Persistent increase in TNF and IL‐1 markers in severe mental disorders suggests trait‐related inflammation: a one year follow‐up study
Mørch, R. H., Dieset, I., Færden, A., Hope, S., Aas, M., Nerhus, M., Gardsjord, E. S., Haram, M., Falk, R. S., Joa, I., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12783 · Cited by 28
Autoantibody profiles associated with clinical features in psychotic disorders
Falk, A. J., Galletly, C., Just, D., Toben, C., Baune, B., Clark, S., Liu, D., Nilsson, P., Månberg, A., & Schubert, K. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01596-0 · Cited by 26
Outcomes of Renal Transplantation in Patients With Bipolar Affective Disorder and Schizophrenia: A National Retrospective Cohort Study
Butler, M., McCartan, D., Cooney, A., Kelly, P. O., Ahmed, I., Little, D. M., MacHale, S., & Conlon, P. J. (2016) · Psychosomatics · doi:10.1016/j.psym.2016.08.010 · Cited by 28
Neurobiology of Schizophrenia (to the Construction of Clinical and Biological Model)
Klyushnik, T. P., Ab, S., Zozulya, S. A., & Voronova, E. I. (2021) · Psikhiatriya · doi:10.30629/2618-6667-2021-19-1-6-15 · Cited by 27
Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls
Goldsmith, D. R., Massa, N., Pearce, B. D., Wommack, E. C., Alrohaibani, A., Goel, N., Cuthbert, B. N., Fargotstein, M., Felger, J. C., Haroon, E., et al. (2020) · Schizophrenia · doi:10.1038/s41537-020-0098-4 · Cited by 29
Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
Ullah, I., Awan, H. A., Aamir, A., Diwan, M. N., de Filippis, R., Awan, S., Irfan, M., Fornaro, M., Ventriglio, A., Vellante, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313032 · Cited by 30
Obesity and the Brain
Karczewski, J., Zielińska, A., Staszewski, R., Eder, P., Dobrowolska, A., & Souto, E. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116145 · Cited by 27
Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia
Baek, S.-H., Kim, H., Kim, J., Ryu, S., Lee, J., Kim, J., Shin, I., & Kim, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071137 · Cited by 31
Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: A prospective cohort study
Zhang, T., Zeng, J., Wei, Y., Ye, J., Tang, X., Xu, L., Hu, Y., Cui, H., Xie, Y., Tang, Y., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114938 · Cited by 27
Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness
Jensen, S. B., Sheikh, M. A., Akkouh, I. A., Szabó, A., O’Connell, K. S., Lekva, T., Engh, J. A., Agartz, I., Elvsåshagen, T., Ormerod, M. B. E. G., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac191 · Cited by 26
Schizophrenia as metabolic disease. What are the causes?
Helaly, A. M., & Ghorab, D. S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-022-01147-6 · Cited by 27
The potential of psychedelics for the treatment of Alzheimer's disease and related dementias
Winkelman, M., Szabó, A., & Frecska, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.07.003 · Cited by 33
The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia
Misiak, B., Samochowiec, J., Kowalski, K., Gäebel, W., Bassetti, C. L., Chan, A., Gorwood, P. A. P. M., Papiol, S., Dom, G., Volpe, U., et al. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2432 · Cited by 31
Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation
Kajitani, K., Yanagimoto, K., & Nakabeppu, Y. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4683-9 · Cited by 27
Comment on Analyses and Conclusions of “Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study”
Narendran, R., & Frankle, W. G. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15111417 · Cited by 27
Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models
Chase, K. A., Feiner, B., Ramaker, M. J., Hu, E., Rosen, C., & Sharma, R. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216463 · Cited by 26
Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability
Wang, Y., Wei, Y., Edmiston, E. K., Womer, F. Y., Zhang, X., Duan, J., Zhu, Y., Zhang, R., Yin, Z., Zhang, Y., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.044 · Cited by 26
Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study
Engh, J. A., Ueland, T., Agartz, I., Andreou, D., Aukrust, P., Boye, B., Bøen, E., Drange, O. K., Elvsåshagen, T., Hope, S., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab106 · Cited by 27
Gut mycobiota dysbiosis in drug-naïve, first-episode schizophrenia
Yuan, X., Li, X., Kang, Y., Pang, L., Hei, G., Zhang, X., Wang, S., Zhao, X., Zhang, S., Tao, Q., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.10.011 · Cited by 26
Association of serum homocysteine levels with intestinal flora and cognitive function in schizophrenia
Li, H., Li, H., Zhu, Z., Xiong, X., Huang, Y., Feng, Y., Li, Z., Wu, K., & Wu, F. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.01.045 · Cited by 26
The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts behavioural deficits induced by the NMDA receptor antagonist ketamine in rats
Zoupa, E., Gravanis, A., & Pitsikas, N. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.001 · Cited by 26
Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles
Arakawa, Y., Yokoyama, K., Tasaki, S., Kato, J., Nakashima, K., Takeyama, M., Nakatani, A., & Suzuki, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220389 · Cited by 27
Infections, antibiotic treatment and the Microbiome in relation to schizophrenia
Klein‐Petersen, A. W., Köhler‐Forsberg, O., & Benros, M. E. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.033 · Cited by 28
Psychopharmacology: From serendipitous discoveries to rationale design, but what next?
Robinson, E. S. J. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818812629 · Cited by 28
Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients
Yan, J., Chen, Y., Ju, P., Gao, J., Zhang, L., Li, J., Wang, K., Zhang, J., Li, C., Xia, Q., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.834539 · Cited by 25
Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia
Chen, W., Gou, M., Wang, L., Li, N., Li, W., Tong, J., Zhou, Y., Xie, T., Yu, T., Feng, W., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.03.014 · Cited by 26
Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site
Takahashi, M., So, T. Y., Chamberlain-Evans, V., Hughes, R., Yam‐Puc, J. C., Kania, K., Ruhle, M., Mann, T., Schuijs, M. J., Coupland, P. G., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.ade2094 · Cited by 23
Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis
Hatziagelaki, E. E., Tsiavou, A., Gerasimou, C., Vavougios, G. D., Spathis, A., Laskos, E., Papageorgiou, C., Douzenis, A., Christodoulou, G. N., Stefanis, N., et al. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7285 · Cited by 25
Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin
Hanger, B., Couch, A. C. M., Rajendran, L., Srivastava, D. P., & Vernon, A. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00789 · Cited by 23
Can prebiotics assist in the management of cognition and weight gain in schizophrenia?
Kao, A. C.-C., Burnet, P. W. J., & Lennox, B. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.027 · Cited by 24
Self-citation
The schizophrenia and gut microbiota: A bibliometric and visual analysis
Yang, C., Lin, X., Wang, X., Liu, H., Huang, J., & Wang, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1022472 · Cited by 26
Over-expression of TGF-β1 gene in medication free Schizophrenia
Amoli, M. M., Khatami, F., Arzaghi, S. M., Enayati, S., & Nejatisafa, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.009 · Cited by 25
Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort
Khandaker, G. M., Štochl, J., Zammit, S., Lewis, G., Dantzer, R., & Jones, P. B. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.11.028 · Cited by 24
Self-citation
Post-traumatic stress disorder, dyssomnias, and metabolic syndrome
Serhiyenko, V. A., Sehin, V. B., Pankiv, V. І., & Serhiyenko, A. A. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.1.2024.1359 · Cited by 25
Ambient Air Pollution and Hospitalizations for Schizophrenia in China
Bai, L., Jiang, Y., Wang, K., Xie, C., Yan, H., You, Y., Liu, H., Chen, J., Wang, J., Chen, W., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.36915 · Cited by 23
Integrating Clinical Data and Imputed Transcriptome from GWAS to Uncover Complex Disease Subtypes: Applications in Psychiatry and Cardiology
Yin, L., Chau, C. K., Sham, P. C., & So, H. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.10.012 · Cited by 23
In Vitro Analysis of Biological Activity of Circulating Cell-Free DNA Isolated from Blood Plasma of Schizophrenic Patients and Healthy Controls
Ershova, E. S., Шмарина, Г. В., Porokhovnik, L. N., Zakharova, N. V., Kostyuk, G. P., Umriukhin, P. E., Kutsev, S. I., Sergeeva, V. A., Veiko, N. N., & Kostyuk, S. V. (2022) · Genes · doi:10.3390/genes13030551 · Cited by 25
Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia
Kostrzewa, R. M., Nowak, P. G., Brus, R., & Brown, R. W. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1757-0 · Cited by 23
Where Do Epigenetics and Developmental Origins Take the Field of Developmental Psychopathology?
Nigg, J. T. (2016) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-015-0121-9 · Cited by 24
Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia
Afshari, P., Yao, W., & Middleton, F. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183854 · Cited by 25
Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
Fathian, F., Løberg, E., Gjestad, R., Steen, V. M., Kroken, R. A., Jørgensen, H. A., & Johnsen, E. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.25 · Cited by 24
Blood brain barrier inflammation and potential therapeutic role of phytochemicals
Welcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100177 · Cited by 22
Severe psychiatric disorders and general medical comorbidities: inflammation-related mechanisms and therapeutic opportunities
Teixeira, A. L., Martins, L. B., Berk, M., & Bauer, M. E. (2022) · Clinical Science · doi:10.1042/cs20211106 · Cited by 22
Current Strategies and Future Directions of Wearable Biosensors for Measuring Stress Biochemical Markers for Neuropsychiatric Applications
Sheffield, Z., Paul, P., Krishnakumar, S., & Pan, D. (2024) · Advanced Science · doi:10.1002/advs.202411339 · Cited by 24
Why Is Clozapine Uniquely Effective in Treatment-Resistant Schizophrenia? A Review and Proposal
Murray, R. M., Egerton, A., Gao, Y., Grace, A. A., Howes, O. D., Jauhar, S., Leucht, S., Chen, E. Y. H., MacCabe, J. H., McCutcheon, R. A., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.06.011 · Cited by 27
Stem Cell-Derived Neurons in the Development of Targeted Treatment for Schizophrenia and Bipolar Disorder
Watmuff, B., Liu, B., & Karmacharya, R. (2017) · Pharmacogenomics · doi:10.2217/pgs-2016-0187 · Cited by 22
Networks of blood proteins in the neuroimmunology of schizophrenia
Jeffries, C. D., Perkins, D. O., Fournier, M., Kim, Q., Cuénod, M., Khadimallah, I., Domenici, E., Addington, J., Bearden, C. E., Cadenhead, K. S., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0158-y · Cited by 23
Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia
Rodrigues, J. E., Martinho, A., Santa, C., Madeira, N. G. G. F., Coroa, M., Santos, V., Martins, M. J., Pato, C. N., Macedo, A., & Manadas, B. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094917 · Cited by 22
The preclinical discovery and development of paliperidone for the treatment of schizophrenia
Wesołowska, A., Jastrzębska‐Więsek, M., Cios, A., & Partyka, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1682994 · Cited by 22
The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings
van Hooijdonk, C. F. M., van der Pluijm, M., Bosch, I., van Amelsvoort, T., Booij, J., de Haan, L., Selten, J., & van de Giessen, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.12.008 · Cited by 21
Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System
Sotoyama, H., Namba, H., Tohmi, M., & Nawa, H. (2023) · Biomolecules · doi:10.3390/biom13020372 · Cited by 24
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis
Foley, É. M., Griffiths, S. L., Murray, A., Rogers, J. C., Zuelli, F. M. D. G. C., Hickinbotham, H., Warwick, E., Wilson, M., Kaşer, M., Murray, G. K., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067944 · Cited by 25
Self-citation
Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring
Perez-Palomar, B., Erdozain, A. M., Erkizia-Santamaría, I., Ortega, J. E., & Meana, J. J. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10070-1 · Cited by 22
Sexual dimorphism of the cerebellar vermis in schizophrenia
Womer, F. Y., Tang, Y., Harms, M. P., Bai, C., Chang, M., Jiang, X., Wei, S., Wang, F., & Barch, D. M. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.028 · Cited by 23

Authors: Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B.
Affiliations: University of Cambridge (GB)
University of Oxford (GB)
Johns Hopkins University (US)
ORCID: Khandaker, Golam M
Cousins, Lesley
Lennox, Belinda R
Yolken, Robert
Jones, Peter B
Venue: The Lancet Psychiatry
Publisher: Elsevier BV
Published: 2015-03
Volume: 2
Issue: 3
Pages: 258-270
ISSN: 2215-0366 (ISSN-L)
DOI: 10.1016/s2215-0366(14)00122-9
PMC: PMC4595998
OpenAlex: W2121637331
Cited by: 926
References: 135
Citations by year: 2026: 82 · 2025: 81 · 2024: 111 · 2023: 104 · 2022: 94 · 2021: 105 · 2020: 78 · 2019: 86 · 2018: 62 · 2017: 63 · 2016: 54 · 2015: 5
FWCI: 3.45
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Psychiatry (publishedVersion)
PubMed (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Apollo (University of Cambridge) (acceptedVersion)
Explore Bristol Research (submittedVersion)
Funders: Wellcome Trust to GMK ((094790/Z/10/Z; 2010-'13))
National Institute of Mental Health ((MH-94268))
Wellcome Trust ((095844/Z/11/Z and 088869/Z/09/Z))
National Institute for Health Research ((RP-PG-0606–1335))
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: schizophrenia, inflammation, immunity, innate immune response, adaptive immune response, infection, blood-brain barrier, anti-inflammatory agents, psychosis, pathophysiology, treatment
MeSH terms: Humans, Immune System, Inflammation, Schizophrenia, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks